Search results
Showing 4066 to 4080 of 8927 results
Evidence summaries: new medicines – Interim process statement (PMG1)
This interim process statement sets out to guide the development of 'Evidence summaries: new medicines' (ESNMs). It provides an overview of the key process principles and describes all stages of the development of ESNMs
Methods for the development of NICE public health guidance (third edition) (PMG4)
This manual describes the methods used by the Centre for Public Health Excellence (CPHE) in NICE to develop and update public health guidance
These are the main stages in the multiple technology appraisal process used before April 2018.
The key stages in development of our quality standards
Summaries of the best available evidence for selected medicines that are considered to be of significance to the NHS.
Agenda and papers of the NICE public board meeting on 13 December 2023
Agenda and papers of the NICE public board meeting on 16 December 2022
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios Learning disability settings {"@context":"http://schema
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios Mental health services {"@context":"http://schema.org"
NICE priority methodological research areas.
Home What NICE does Our guidance About technology appraisal guidance Our methods and processes (health technology evaluation manual)...
NICE Listens is our programme of deliberative public engagement. It's used to give us an understanding of public opinion on moral, ethical and social value issues.
Bisphosphonates for treating osteoporosis Patient decision aid What is osteoporosis and how can bisphosphonates help? Everyone's bones get weaker as...
Engage at the optimal time for your technology appraisal, to achieve NICE guidance at the same time as marketing authorisation.
How to use NICE guidance to reduce health inequalities in people experiencing cardiovascular disease (CVD).